← Back to Search

Behavioral Intervention

Reciprocal Intervention Teaching (RIT) for Autism Spectrum Disorder

N/A
Recruiting
Led By Wendy L Stone, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 12-month follow-up
Awards & highlights

Study Summary

This trial will test whether a brief, inexpensive training can improve providers' comfort and effectiveness in working with families of children with social communication concerns, as well as improving child and family outcomes.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 12-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Caregiver Use of RIT Strategies
Child Motor Imitation - In Vivo
Child Motor Imitation - Parent Report
+4 more
Secondary outcome measures
Caregiver Top Concerns
Child Adaptive Behavior
Child Language
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RIT Training GroupExperimental Treatment1 Intervention
Providers in the RIT group (n=30) will receive an 8-hour virtual workshop (2 half-days) on RIT implementation and caregiver coaching. Each provider will invite 2 families in their caseload to participate in the study. Providers will coach families in the use of RIT. One intervention session for each enrolled family will be videotaped and scored for RIT fidelity.
Group II: Daily RoutinesActive Control1 Intervention
Providers in the Routines Control group (n=30) will receive a 3-hour virtual workshop focused on helping providers coach caregivers on how to increase children's participation and social engagement during everyday home routines (i.e., snack time, bedtime, bath time, and family playtime). Each provider will invite 2 families in their caseload to participate in the study. One intervention session for each enrolled family will be videotaped and scored for RIT fidelity to ensure contamination has not occurred and the control condition providers are not utilizing RIT strategies.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,231 Total Patients Enrolled
13 Trials studying Autism Spectrum Disorder
3,518 Patients Enrolled for Autism Spectrum Disorder
Congressionally Directed Medical Research ProgramsFED
47 Previous Clinical Trials
6,458 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
186 Patients Enrolled for Autism Spectrum Disorder
Wendy L Stone, PhDPrincipal InvestigatorUniversity of Washington
3 Previous Clinical Trials
1,108 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
1,067 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who can partake in this trial’s proceedings?

"This clinical trial is enrolling 180 individuals with an Autism Spectrum Disorder aged between 18 and 80 months. To qualify, participants must have a caseload that includes at least two children suspected of having ASD; they should be able to partake in intervention sessions or tele-video research visits recorded by staff, can speak and read English (or Spanish for caregivers), are employed by participating Part C practices/agencies, willing to invite families into this study and older than 18 years old. Additionally the child needs to receive services from one of the enrolled agencies plus attend regular appointments with said provider while being between 18 - 30 months old along either possessing a"

Answered by AI

What benefits are researchers hoping to demonstrate through this investigation?

"The 6-month study will measure the efficacy of its intervention through changes in Child Motor Imitation - In Vivo. Secondary outcomes involve Parenting Stress (Parenting Stress Index-Short Form), Child Language (MacArthur Bates Communicative Development Inventory) and Parenting Self-Efficacy (Parenting Efficacy Scale)."

Answered by AI

What is the current enrollment count for this experiment?

"Affirmative. According to information available via clinicaltrials.gov, this medical study is actively recruiting participants since it was initially posted on May 15th 2021 and last modified on June 15th 2022. The trial seeks 180 patients from a single location."

Answered by AI

Are individuals over 25 years of age eligible to enrol in this trial?

"This trial seeks participants aged between 18 months and 80 years."

Answered by AI

Are any individuals currently eligible to join this experimental investigation?

"Affirmative. Clinicaltrials.gov's record of the trial confirms that it is currently enrolling participants; this experiment was initially posted on May 15th 2021 and has been updated most recently on June 15th 2022. The study necessitates 180 individuals at 1 research centre to participate in it."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
< 18
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Assessing the Effectiveness of Reciprocal Imitation Teaching in Part C Early Intervention Settings (Sprout Study)
Wendy Stone 2021. "Assessing the Effectiveness of Reciprocal Imitation Teaching in Part C Early Intervention Settings (Sprout Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05425277.
~31 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top